Companies / VYNE Therapeutics Inc.
VYNE Therapeutics Inc.
Financials · FY2025
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 28, 2021 | Perceptive Advisors LLC 10% owner | Buy Open-market buy | Common Stock | $10.00M | +4.2M +18.44% | 27,095,819 81.24% of shares | high |
| May 6, 2021 | Perceptive Advisors LLC 10% owner | Sell Open-market sale | Common Stock | $3.67M | -1.0M -14.76% | 5,773,954 17.31% of shares | medium |
| Aug 12, 2021 | Perceptive Advisors LLC 10% owner | Sell Open-market sale | Common Stock | $755.7K | -339K -5.87% | 5,435,057 16.30% of shares | medium |
| Aug 13, 2021 | Perceptive Advisors LLC 10% owner | Sell Open-market sale | Common Stock | $460.0K | -250K -4.60% | 5,185,057 15.55% of shares | medium |
| Aug 16, 2021 | Perceptive Advisors LLC 10% owner | Sell Open-market sale | Common Stock | $435.0K | -250K -4.82% | 4,935,057 14.80% of shares | medium |
| Mar 15, 2021 | Lepore Patrick G Director | Buy Open-market buy | Common Stock | $92.6K | +13K +100.00% | 25,000 0.07% of shares | medium |
| Dec 31, 2024 | Domzalski David CEO | Other Withheld for taxes | Common Stock | $82.2K | -25K -4.90% | 476,061 1.43% of shares | low |
| Jul 23, 2026 | Domzalski David CEO | Other Withheld for taxes | Common Stock | $71.3K | -79K -18.61% | 347,174 1.04% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VYNE | common | 92941V308 |
| VYNE | unknown | 92941V407 |